Abstract
In cancer imaging, many different modalities are used that each have their specific features, leading to the combined use of different techniques for the detection, staging and treatment evaluation of cancer. Optical imaging using near-infrared fluorescence light is a new imaging modality that has recently emerged in the field of cancer imaging. After extensive preclinical research, the first steps of translation to the clinical practice are currently being made. In this article, we discuss the preclinical and clinical results of near-infrared optical imaging for non-invasive detection and classification of tumors, therapy monitoring, sentinel lymph node procedures, and image-guided cancer surgery. Widespread availability of imaging systems and optical contrast agents will enable larger studies on their clinical benefit and can help establish a definitive role in clinical practice.
Keywords: Image-guided surgery, near-infrared fluorescence, optical imaging, translational research, preclinical and clinical results, visualizing anatomy, computed tomography (CT), magnetic resonance imaging (MRI), clinical practice, positron emission tomography (PET), single-photon-emission computed tomography (SPECT), image anatomical, hemoglobin, absorption coefficient, hypermetabolism
Current Pharmaceutical Biotechnology
Title: Translational Optical Imaging in Diagnosis and Treatment of Cancer
Volume: 13 Issue: 4
Author(s): Stijn Keereweer, Merlijn Hutteman, Jeroen D.F. Kerrebijn, Cornelis J.H. van de Velde, Alexander L. Vahrmeijer and Clemens W.G.M. Lowik
Affiliation:
Keywords: Image-guided surgery, near-infrared fluorescence, optical imaging, translational research, preclinical and clinical results, visualizing anatomy, computed tomography (CT), magnetic resonance imaging (MRI), clinical practice, positron emission tomography (PET), single-photon-emission computed tomography (SPECT), image anatomical, hemoglobin, absorption coefficient, hypermetabolism
Abstract: In cancer imaging, many different modalities are used that each have their specific features, leading to the combined use of different techniques for the detection, staging and treatment evaluation of cancer. Optical imaging using near-infrared fluorescence light is a new imaging modality that has recently emerged in the field of cancer imaging. After extensive preclinical research, the first steps of translation to the clinical practice are currently being made. In this article, we discuss the preclinical and clinical results of near-infrared optical imaging for non-invasive detection and classification of tumors, therapy monitoring, sentinel lymph node procedures, and image-guided cancer surgery. Widespread availability of imaging systems and optical contrast agents will enable larger studies on their clinical benefit and can help establish a definitive role in clinical practice.
Export Options
About this article
Cite this article as:
Keereweer Stijn, Hutteman Merlijn, D.F. Kerrebijn Jeroen, J.H. van de Velde Cornelis, L. Vahrmeijer Alexander and W.G.M. Lowik Clemens, Translational Optical Imaging in Diagnosis and Treatment of Cancer, Current Pharmaceutical Biotechnology 2012; 13 (4) . https://dx.doi.org/10.2174/138920112799436294
DOI https://dx.doi.org/10.2174/138920112799436294 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Sphingolipid Signaling Pathways as Potential Therapeutic Targets in Gliomas
Mini-Reviews in Medicinal Chemistry Mitochondria Sentencing About Cellular Life and Death: A Matter of Oxidative Stress
Current Pharmaceutical Design Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets Tropism-Modified Adenoviral and Adeno-Associated Viral Vectors for Gene Therapy
Current Gene Therapy Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer
Current Cancer Drug Targets Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
Current Drug Delivery Antiangiogenic Therapy
Current Pharmaceutical Design Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Current Pharmaceutical Biotechnology Current Status of Delivery Systems to Improve Target Efficacy of Oligonu-cleotides
Current Pharmaceutical Design Hepatoma-Derived Growth Factor in Carcinogenesis and Cancer Progression
Current Drug Therapy Systems Cytogenomics: Are We Ready Yet?
Current Genomics Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Current Inhibitors of Checkpoint Kinase 2
Current Medicinal Chemistry Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Recent Patents on Anti-Cancer Drug Discovery Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer
Current Pharmaceutical Design Cyclodextrins and their Derivatives as Carrier Molecules in Drug and Gene Delivery Systems
Current Organic Chemistry